← All trials
NCT05281328
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 28, 2022
- Primary completion
- Jan 31, 2024
- Completion date
- Aug 31, 2024
- First posted
- Mar 16, 2022
- Last posted
- Nov 21, 2022
- Enrollment
- 69
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Camurus ABLead sponsor
- Radboud UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.